Visium Asset Management’s Boston Scientific BSX Stock Holding History

Visium Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-811,227	Closed	-$15.3M	–	368
2016 Q1	$15.3M	Sell	811,227 -593,073	-42%	-$10.4M	0.26%	97
2015 Q4	$25.9M	Buy	1,404,300 +1,393,000	+12,327%	+$25M	0.39%	46
2015 Q3	$185K	Buy	+11,300	New	+$193K	﹤0.01%	812
2015 Q2	–	Sell	-1,975,283	Closed	-$35.1M	–	1144
2015 Q1	$35.1M	Buy	1,975,283 +525,139	+36%	+$8.3M	0.52%	33
2014 Q4	$19.2M	Buy	+1,450,144	New	+$18.5M	0.27%	69
2014 Q3	–	Sell	-220,555	Closed	-$2.82M	–	1049
2014 Q2	$2.82M	Sell	220,555 -2,283,648	-91%	-$29.7M	0.04%	331
2014 Q1	$33.9M	Buy	2,504,203 +559,042	+29%	+$7.34M	0.55%	32
2013 Q4	$23.4M	Buy	+1,945,161	New	+$23M	0.46%	45

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Visium Asset Management's BSX Position: Q2 2016 in Review

Visium Asset Management sold out of Boston Scientific (BSX) in Q2 2016, closing a stake of 811,227 shares — an estimated $15.3M sold.

Visium Asset Management first reported a position in BSX in Q4 2013 and held it in 8 quarters. The position peaked at $35.1M in Q1 2015. 544 funds tracked by Wall St. Rank hold BSX as of Q2 2016.

Visium Asset Management reported no remaining Boston Scientific position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 811,227 Boston Scientific shares in Q2 2016, an estimated $15.3M.
Visium Asset Management first reported a position in Boston Scientific in Q4 2013 and held it in 8 quarters.
Visium Asset Management's Boston Scientific position peaked at $35.1M in Q1 2015.
544 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.